FY26 B1 foundation care pharm chemo JAN 26
Ended Awarded Last action
- Contract number
- 15B40626F00000067
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Federal Correctional Complex Florence
Correctional Facilities, Department of Justice
- Obligated
- $14,386
Award facts
- Contract value 100% obligated
-
- $14,385.75 Current, with exercised options
- $14,390.75 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Sand Lake, FL 32819, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $93 | |
| Original award | $14,292 |
About this award
Takeda Pharmaceuticals America, Inc. received a delivery order from Federal Correctional Complex Florence valued at $14,390.75 for foundation care pharmaceutical chemotherapy products. The award, issued on January 1, 2026, with an ultimate completion date of March 11, 2026, is structured as a firm fixed-price delivery order with no small business set-aside. Performance will be conducted in Orlando, Florida. This delivery order is a child contract under Takeda's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), a $2.89 billion multiple-award vehicle extending through September 28, 2030, which establishes a framework enabling federal agencies to procure specialized pharmaceutical products without conducting separate competitive procurements.
Takeda Pharmaceuticals America, a foreign-owned subsidiary of Takeda Pharmaceutical Company Limited, is a major supplier of specialized oncology medications to federal healthcare agencies. The company maintains significant indefinite delivery vehicles with federal agencies, most notably a $43.8 million blanket purchase agreement with the Department of Veterans Affairs for ICLUSIG (ponatinib) supply through October 2026. This delivery order to Federal Correctional Complex Florence represents an expansion of Takeda's federal healthcare supplier role beyond its primary focus on Veterans Affairs medical facilities, demonstrating the company's role as a critical provider of specialty pharmaceuticals across multiple federal agencies and correctional healthcare systems.
Quick answers
Who was awarded contract 15B40626F00000067?
15B40626F00000067 was awarded to Takeda Pharmaceuticals America, Inc. by Federal Correctional Complex Florence (Correctional Facilities) on January 1, 2026.
How much is contract 15B40626F00000067 worth?
The government has obligated $14,386 on 15B40626F00000067. Its potential value, with all options, is $14,391.
Is contract 15B40626F00000067 an order under another contract?
Yes. 15B40626F00000067 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B40626F00000067 competed?
The extent of competition for 15B40626F00000067 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award